🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A single 125 mg oral dose of the investigational compound PD-0332991 will b...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01821066
Treatments Being Tested
Primary Objective: To determine whether amcenestrant per overall survival ...
Status
Terminated
Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Start Date
2019-10-22
Trial ID
NCT04059484
Treatments Being Tested
The purpose of this study was to give access to postmenopausal women with e...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00649090
Treatments Being Tested
Men and post- or induced menopausal women with ER\[+\] and/or PgR\[+\], HER...
Status
Completed
Location
Hospital General Universitario de Alicante
Start Date
2020-10-23
Trial ID
NCT04300790
Treatments Being Tested
The primary objectives of this study are to determine whether the study dru...
Status
Completed
Location
Stanford University
Start Date
2017-12-07
Trial ID
NCT03229499
Treatments Being Tested
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
The purpose of this study is to identify the highest tolerable dose of pyro...
Status
Unknown
Location
Multiple Locations
Start Date
2019-08-15
Trial ID
NCT03997539
Treatments Being Tested
The primary goal of this study is to evaluate the effectiveness of elacestr...
Status
Recruiting
Location
Southern Cancer Center, PC
Start Date
2024-09-27
Trial ID
NCT06492616
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic characteristic...
Status
Completed
Location
Korea University Guro Hosptial
Start Date
2019-02-28
Trial ID
NCT03824171
Treatments Being Tested
To explore the efficacy and safety of Chidamide combined with endocrine for...
Status
Recruiting
Location
天津市肿瘤医院
Start Date
2023-05-16
Trial ID
NCT05890287
Treatments Being Tested